The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
AI Sentiment Analysis Is Becoming Investors’ New Early‑Warning Signal
AI-powered sentiment analysis is giving real estate investors a major edge by scanning millions of online conversations to detect market shifts long before traditional data responds. From predicting neighborhood momentum to spotting declining tenant satisfaction, this technology captures real-time public emotion across office, retail, and multifamily sectors. As trends in sentiment become as important as demographics and NOI, professionals who understand these tools will stay ahead of the next market move.
